BMC GenomicsGeneticsPeer-reviewed journal article
Widespread genetic testing control inherited polycystic kidney disease in cats
Hisashi Ukawa, 木田 朱音, Kai Ataka, Ryo Horie, Yuki MatsumotoiD
Abstract
A genetic variant of PKD1 in cats, which causes polycystic kidney disease (PKD), is a target for direct-to-consumer genetic testing to assess PKD risk; however, its effect on genetic structure in cat populations remains unexplored. Therefore, in this study, we aimed to examine the changes in feline PKD and the PKD1 variant across breeds and over time using a large dataset of 110,325 insured and 61,968 genetic-tested cats from 14 breeds. Results revealed that the PKD1 variant frequency significantly decreased, with a reduction of 42.6% before 2019 and after 2022. Systematic genomic analysis revealed no differences in genetic structure or inbreeding levels. The effective population size of cats with the PKD1 variant decreased between points. Overall, these findings highlight the potential of direct-to-consumer genetic testing in promoting more optimized breeding practices and enhancing feline welfare.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 41th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Large-scale epidemiological study on feline autosomal dominant polycystic kidney disease and identification of novel PKD1 gene variants
Fumitaka Shitamori, Ayaka Nonogaki, … Shingo Maeda·bioRxiv·Mar 23, 2023
- Genetic epidemiology of blood type, disease and trait variants, and genome-wide genetic diversity in over 11,000 domestic cats
Heidi Anderson, Stephen Davison, … Jonas Donner·PLoS GeneticsPeer-reviewed·Jun 16, 2022
- Negative selection on a SOD1 mutation limits canine degenerative myelopathy while avoiding inbreeding
Hisashi Ukawa, Noriyoshi Akiyama, … Yuki Matsumoto·Genome Biology and EvolutionPeer-reviewed·Dec 18, 2023
- Leveraging genomic biobanks to enhance genetic testing outcomes for kidney disease
Gretchen M. Urban, Kulsoom Mohammad, … Alex R. Chang·medRxiv·Nov 7, 2025
- Clinical utility of genetic and genomic testing in the precision diagnosis and management of pediatric patients with kidney and urinary tract diseases
Nasim Bekheirnia, Kevin E. Glinton, … Mir Reza Bekheirnia·Kidney360Peer-reviewed·Oct 30, 2020
- Pedigree-tracking improved population monitoring of recessive disease-causing alleles in pedigreed canine populations
Rosalind Craddock, Mateja Janeš, … Gregor Gorjanc·bioRxiv·Oct 29, 2026